Correlating skin toxicity and steroid treatment with outcomes of anti-PD-1 therapy for patients with metastatic melanoma

被引：0
|
作者：
Quach, Henry T. [1 ]
Johnson, Douglas B. [2 ]
Dewan, Anna K. [3 ]
机构：
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[3] Vanderbilt Univ, Med Ctr, Dept Dermatol, Nashville, TN USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
10388
引用
收藏
页码：AB39 / AB39
页数：1
相关论文
共 50 条
  • [1] Anti-PD-1 tolerance after severe toxicity with ipilimumab therapy in metastatic melanoma patients.
    Brunot, Angelique
    Jeudy, Geraldine
    Tas, Mathieu
    Guillot, Bernard
    Kramkimel, Nora
    Mortier, Laurent
    Mansard, Sandrine
    Lebbe, Celeste
    Blom, Astrid
    Le Corre, Yannick
    Montaudie, Henri
    Prey, Sorilla
    Campillo-Gimenez, Boris
    Lesimple, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Limited-duration anti-PD-1 therapy for patients with metastatic melanoma
    Makela, Siru
    Kohtamaki, Laura
    Laukka, Marjut
    Juteau, Susanna
    Hernberg, Micaela
    ACTA ONCOLOGICA, 2020, 59 (04) : 438 - 443
  • [3] Impact of age on toxicity in patients treated with anti-PD-1 therapy for melanoma
    Shah, Kaustav P.
    Song, Haocan
    Ye, Fei
    Salem, Joe-Elie
    Balko, Justin
    Johnson, Douglas B.
    CANCER RESEARCH, 2020, 80 (16)
  • [4] Resistance patterns to anti-PD-1 therapy in metastatic melanoma
    Ozgun, Alpaslan
    Sondak, Vernon K.
    Markowitz, Joseph
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (06)
  • [5] The importance of anti-PD-1 dosing in the treatment of patients with inoperable or metastatic melanoma
    Cybulska-Stopa, B.
    Czarnecka, A. M.
    Ostaszewski, K.
    Zietek, M.
    Piejko, K.
    Dziura, R.
    Galus, L.
    Ziolkowska, B. E.
    Kieszko, S.
    Kempa-Kaminska, N.
    Calik, J.
    Seredynska, J.
    Rogala, P.
    Drosik-Kwasniewska, A.
    Kaminska-Winciorek, G.
    Kubiatowski, T.
    Suwinski, R.
    Mackiewicz, J.
    Rutkowski, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S899 - S900
  • [6] Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy
    Bowyer, S.
    Prithviraj, P.
    Lorigan, P.
    Larkin, J.
    McArthur, G.
    Atkinson, V.
    Millward, M.
    Khou, M.
    Diem, S.
    Ramanujam, S.
    Kong, B.
    Liniker, E.
    Guminski, A.
    Parente, P.
    Andrews, M. C.
    Parakh, S.
    Cebon, J.
    Long, G. V.
    Carlino, M. S.
    Klein, O.
    BRITISH JOURNAL OF CANCER, 2016, 114 (10) : 1084 - 1089
  • [7] Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy
    S Bowyer
    P Prithviraj
    P Lorigan
    J Larkin
    G McArthur
    V Atkinson
    M Millward
    M Khou
    S Diem
    S Ramanujam
    B Kong
    E Liniker
    A Guminski
    P Parente
    M C Andrews
    S Parakh
    J Cebon
    G V Long
    M S Carlino
    O Klein
    British Journal of Cancer, 2016, 114 : 1084 - 1089
  • [8] Lichenoid Dermatitis in Three Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy
    Joseph, Richard W.
    Cappel, Mark
    Goedjen, Brent
    Gordon, Matthew
    Kirsch, Brandon
    Gilstrap, Cheryl
    Bagaria, Sanjay
    Jambusaria-Pahlajani, Anokhi
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (01) : 18 - 22
  • [9] Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma
    Liniker, E.
    Menzies, A. M.
    Kong, B. Y.
    Cooper, A.
    Ramanujam, S.
    Lo, S.
    Kefford, R. F.
    Fogarty, G. B.
    Guminski, A.
    Wang, T. W.
    Carlino, M. S.
    Hong, A.
    Long, G. V.
    ONCOIMMUNOLOGY, 2016, 5 (09):
  • [10] Anti-PD-1 Therapy in Melanoma
    Moreno, Blanca Hornet
    Parisi, Giulia
    Robert, Lidia
    Ribas, Anton
    SEMINARS IN ONCOLOGY, 2015, 42 (03) : 466 - 473
12345